The global coronary stent market size was valued at USD 7.02 billion in 2025 and is projected to grow from USD 7.38 billion in 2026 to USD 12.26 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 6.54% during the forecast period.

The global Coronary Stent Market is expanding steadily, driven by the rising global prevalence of cardiovascular and coronary artery diseases, a growing elderly demographic, and continuous technological innovations in percutaneous coronary intervention (PCI) procedures.

Market Overview

The coronary stent sector encompasses specialized medical devices—such as drug-eluting stents, bare-metal stents, and bioresorbable scaffolds—inserted into narrowed coronary arteries during angioplasty procedures to maintain adequate blood flow to the heart muscle. By offering minimally invasive alternatives to traditional open-heart surgeries, these devices effectively treat atherosclerosis and acute or chronic coronary syndromes across hospitals and specialized cardiac centers worldwide.

Market Insights

Industry insights highlight a strong preference for advanced drug-eluting and self-expandable stents due to their superior clinical efficacy and reduced restenosis rates. Furthermore, expanding healthcare infrastructure in emerging economies, alongside a steady increase in cardiac catheterization laboratory installations, continues to support robust procedural adoption and market revenue growth.

Market Trends

• Continuous technological innovations focusing on reducing stent strut thickness, improving deliverability through tortuous vessels, and introducing smaller diameters.
• Development and commercialization of advanced bioresorbable stents and drug-eluting systems incorporating biodegradable polymers to enhance long-term patient outcomes.
• Growing adoption of minimally invasive percutaneous coronary intervention (PCI) techniques over traditional open-heart surgeries.
• Strategic regulatory approvals and new product launches by leading medical device manufacturers to capture expanded market share.

For detailed market insights, visit the Coronary Stent Market reports: https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065

Market Growth Factors

• Rising global prevalence of coronary artery disease driven by sedentary lifestyles, poor dietary habits, and increasing stress levels.
• Rapid expansion of the aging global population, which exhibits higher biological susceptibility to cardiovascular and heart disorders.
• Technological advancements in stenting procedures reducing manual operational errors and enhancing procedural safety.
• Increasing public healthcare awareness campaigns and government initiatives promoting early cardiovascular screening and diagnosis.

For request sample reports: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/coronary-stents-market-100065

Competitor Analysis

The competitive landscape of the market features prominent global medical technology corporations focusing on research innovations, strategic regulatory approvals, and portfolio expansion. Key market participants include Medtronic, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Abbott Laboratories, and Stentys S.A. These industry leaders invest heavily in clinical trials, advanced drug-eluting stent platforms—such as Medtronic's Onyx Frontier DES—and global distribution networks to maintain strong competitive advantages.